Thermo Fisher Scientific Company Profile (NYSE:TMO)

About Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific logoThermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables. The Analytical Instruments segment provides a range of instruments, consumables, software and services. The Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers controlled temperature technologies products, growth protection and separation products, and water and laboratory products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology - NEC
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NYSE:TMO
  • CUSIP: 88355610
  • Web: www.thermofisher.com
Capitalization:
  • Market Cap: $68.48695 billion
  • Outstanding Shares: 391,219,000
Average Prices:
  • 50 Day Moving Avg: $176.77
  • 200 Day Moving Avg: $163.26
  • 52 Week Range: $139.07 - $182.87
P/E:
  • Trailing P/E Ratio: 31.97
  • Foreward P/E Ratio: 17.07
  • P/E Growth: 1.70
Sales & Book Value:
  • Annual Revenue: $18.74 billion
  • Price / Sales: 3.66
  • Book Value: $55.71 per share
  • Price / Book: 3.15
Dividend:
  • Annual Dividend: $0.60
  • Dividend Yield: 0.3%
Profitability:
  • EBIDTA: $4.69 billion
  • Net Margins: 11.80%
  • Return on Equity: 14.64%
  • Return on Assets: 6.85%
Debt:
  • Debt-to-Equity Ratio: 0.68%
  • Current Ratio: 1.47%
  • Quick Ratio: 0.93%
Misc:
  • Average Volume: 1.39 million shs.
  • Beta: 1.06
  • Short Ratio: 1.66
 
Frequently Asked Questions for Thermo Fisher Scientific (NYSE:TMO)

What is Thermo Fisher Scientific's stock symbol?

Thermo Fisher Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "TMO."

How often does Thermo Fisher Scientific pay dividends? What is the dividend yield for Thermo Fisher Scientific?

Thermo Fisher Scientific announced a quarterly dividend on Wednesday, July 12th. Stockholders of record on Friday, September 15th will be given a dividend of $0.15 per share on Monday, October 16th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.34%. The ex-dividend date of this dividend is Thursday, September 14th. View Thermo Fisher Scientific's Dividend History.

How were Thermo Fisher Scientific's earnings last quarter?

Thermo Fisher Scientific Inc (NYSE:TMO) posted its quarterly earnings results on Wednesday, July, 26th. The company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.03. The firm had revenue of $5 billion for the quarter, compared to analyst estimates of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 14.64%. The firm's revenue for the quarter was up 10.2% compared to the same quarter last year. During the same period in the prior year, the company posted $2.03 earnings per share. View Thermo Fisher Scientific's Earnings History.

Where is Thermo Fisher Scientific's stock going? Where will Thermo Fisher Scientific's stock price be in 2017?

16 brokers have issued 12 month price objectives for Thermo Fisher Scientific's stock. Their forecasts range from $162.00 to $210.00. On average, they expect Thermo Fisher Scientific's stock price to reach $187.93 in the next twelve months. View Analyst Ratings for Thermo Fisher Scientific.

What are analysts saying about Thermo Fisher Scientific stock?

Here are some recent quotes from research analysts about Thermo Fisher Scientific stock:

  • 1. According to Zacks Investment Research, "Over the last three months, Thermo Fisher is trading above the broader Medical - Instruments industry. The company’s last reported first quarter 2017 was quite impressive. The increased 2017 guidance is all the more encouraging indicating the fact that this overall bullish trend will continue through 2017. Moreover we remain encouraged by the company’s series of product launches and acquisitions along with strong growth in emerging markets and better management observed in its customer value proposition. Thermo Fisher’s acquisition of FEI has already started to boost the company’s analytical instruments portfolio. Its recent decision to acquire Pantheon is to expand its biopharma services in Europe. On the flip side, competitive pressure and currency headwinds add woes." (7/11/2017)
  • 2. Evercore ISI analysts commented, "When all is said in done we will remember 4Q as being generally uneventful, with guidance coming in better than feared as investors had become concerned re the impact from slowing biopharma demand (didn't really occur), mixed A&G trends and an incremental headwind from Fx. The level of consistency we see from TMO is unusual in this challenging healthcare environment and likely helps to justify valuation that is certainly not inexpensive on an EV / EBITDA basis (particularly in a rising rate world). That being said with so few places to hide in a difficult healthcare tape, we would expect TMO's superior EPS growth to help shares to remain a preferred equity, particularly given its status as a visible compounder. Thus despite today's sharp move in shares (up a bit more than we would have anticipated) we reiterate our Buy rating as risk / reward continues to be asymmetrically biased upward." (1/31/2017)

Are investors shorting Thermo Fisher Scientific?

Thermo Fisher Scientific saw a increase in short interest during the month of July. As of July 14th, there was short interest totalling 3,746,211 shares, an increase of 77.8% from the June 30th total of 2,107,353 shares. Based on an average trading volume of 1,328,438 shares, the short-interest ratio is currently 2.8 days. Currently, 1.0% of the shares of the company are sold short.

Who are some of Thermo Fisher Scientific's key competitors?

Who are Thermo Fisher Scientific's key executives?

Thermo Fisher Scientific's management team includes the folowing people:

  • Jim P. Manzi, Independent Chairman of the Board
  • Marc N. Casper, President, Chief Executive Officer, Director
  • Stephen Williamson, Chief Financial Officer, Senior Vice President
  • Mark P. Stevenson, Executive Vice President, President, Life Sciences Solutions
  • Seth H. Hoogasian, Senior Vice President, General Counsel, Secretary
  • Patrick M. Durbin, Senior Vice President, President - Specialty Diagnostics
  • Thomas W. Loewald, Senior Vice President, Chief Commercial Officer
  • Daniel P. Shine, Senior Vice President, President, Analytical Instruments
  • Peter E. Hornstra, Vice President, Chief Accounting Officer
  • Dion J. Weisler, Director

Who owns Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Longview Partners Guernsey LTD (1.09%), Bessemer Group Inc. (0.34%), Harbour Capital Advisors LLC (0.31%), Tesco Pension Investment Ltd (0.27%), Diamond Hill Capital Management Inc. (0.18%) and NN Investment Partners Holdings N.V. (0.15%). Company insiders that own Thermo Fisher Scientific stock include Alan J Malus, C Martin Harris, Daniel P Shine, Jim P Manzi, Marc N Casper, Patrick M Durbin, Peter E Hornstra, Peter M Wilver, Scott M Sperling, Seth H Hoogasian, Stephen Williamson, Thomas W Loewald and William G Parrett. View Institutional Ownership Trends for Thermo Fisher Scientific.

Who sold Thermo Fisher Scientific stock? Who is selling Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock was sold by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Hermes Investment Management Ltd., Manning & Napier Advisors LLC, Russell Investments Group Ltd., Swarthmore Group Inc., Great West Life Assurance Co. Can, ING Groep NV and Forsta AP Fonden. Company insiders that have sold Thermo Fisher Scientific stock in the last year include C Martin Harris, Daniel P Shine, Marc N Casper, Peter M Wilver, Seth H Hoogasian, Stephen Williamson and Thomas W Loewald. View Insider Buying and Selling for Thermo Fisher Scientific.

Who bought Thermo Fisher Scientific stock? Who is buying Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock was acquired by a variety of institutional investors in the last quarter, including Harbour Capital Advisors LLC, Rothschild Asset Management Inc., Cornerstone Investment Partners LLC, Bank of Montreal Can, Longview Partners Guernsey LTD, Diamond Hill Capital Management Inc., NN Investment Partners Holdings N.V. and Mn Services Vermogensbeheer B.V.. View Insider Buying and Selling for Thermo Fisher Scientific.

How do I buy Thermo Fisher Scientific stock?

Shares of Thermo Fisher Scientific can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Thermo Fisher Scientific's stock price today?

One share of Thermo Fisher Scientific stock can currently be purchased for approximately $175.27.


MarketBeat Community Rating for Thermo Fisher Scientific (NYSE TMO)
Community Ranking:  3.5 out of 5 (   )
Outperform Votes:  444 (Vote Outperform)
Underperform Votes:  195 (Vote Underperform)
Total Votes:  639
MarketBeat's community ratings are surveys of what our community members think about Thermo Fisher Scientific and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Thermo Fisher Scientific (NYSE:TMO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 14 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $187.93 (7.23% upside)

Analysts' Ratings History for Thermo Fisher Scientific (NYSE:TMO)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/21/2017Bank of America CorporationReiterated RatingBuy$200.00 -> $210.00LowView Rating Details
7/20/2017Cleveland ResearchUpgradeNeutral -> BuyLowView Rating Details
7/17/2017Barclays PLCReiterated RatingOverweight$190.00 -> $200.00LowView Rating Details
7/13/2017Wells Fargo & CompanyReiterated RatingOutperform$195.00 -> $200.00LowView Rating Details
7/10/2017Citigroup Inc.Reiterated RatingBuy$182.00 -> $201.00LowView Rating Details
6/10/2017Deutsche Bank AGSet Price TargetBuy$200.00LowView Rating Details
5/18/2017Cantor FitzgeraldInitiated CoverageOverweight -> Overweight$194.00LowView Rating Details
5/17/2017Jefferies Group LLCReiterated RatingHold$175.00LowView Rating Details
4/29/2017Cowen and CompanyReiterated RatingOutperform$175.00 -> $185.00LowView Rating Details
4/28/2017Morgan StanleyBoost Price TargetOverweight$186.00 -> $192.00LowView Rating Details
4/28/2017BTIG ResearchBoost Price TargetBuy$180.00 -> $190.00LowView Rating Details
4/27/2017Leerink SwannSet Price TargetBuy$187.00LowView Rating Details
1/31/2017Evercore ISIBoost Price TargetBuy$160.00 -> $162.00N/AView Rating Details
12/12/2016Goldman Sachs Group, Inc. (The)Reiterated RatingConviction-Buy -> Conviction-Buy$170.00 -> $168.00N/AView Rating Details
9/22/2016J P Morgan Chase & CoInitiated CoverageOverweight$180.00N/AView Rating Details
7/28/2016MizuhoSet Price TargetBuy$170.00 -> $175.00N/AView Rating Details
3/2/2016Topeka Capital MarketsBoost Price TargetBuy$145.00 -> $155.00N/AView Rating Details
1/29/2016Stifel NicolausLower Price Target$158.00 -> $150.00N/AView Rating Details
1/29/2016KeyCorpLower Price TargetOverweight$152.00 -> $150.00N/AView Rating Details
1/6/2016Avondale PartnersInitiated CoverageOutperform$168.00N/AView Rating Details
10/6/2015ArgusInitiated CoverageBuy$145.00N/AView Rating Details
(Data available from 7/28/2015 forward)

Earnings

Earnings History for Thermo Fisher Scientific (NYSE:TMO)
Earnings by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Earnings History by Quarter for Thermo Fisher Scientific (NYSE TMO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/26/2017Q2 2017$2.27$2.30$4.92 billion$5.00 billionViewN/AView Earnings Details
4/26/2017Q1 2017$2.02$2.08$4.68 billion$4.77 billionViewN/AView Earnings Details
1/31/2017Q416$2.38$2.41$4.98 billion$4.95 billionViewN/AView Earnings Details
10/27/2016Q316$1.97$2.03$4.39 billion$4.49 billionViewListenView Earnings Details
7/28/2016Q216$2.01$2.03$4.50 billion$4.54 billionViewListenView Earnings Details
4/28/2016Q116$1.74$1.80$4.11 billion$4.29 billionViewListenView Earnings Details
1/28/2016Q415$2.11$2.12$4.55 billion$4.65 billionViewListenView Earnings Details
10/21/2015Q315$1.79$1.80$4.10 billion$4.12 billionViewListenView Earnings Details
7/22/2015Q215$1.78$1.84$4.17 billion$4.27 billionViewListenView Earnings Details
4/22/2015Q115$1.61$1.63$4.01 billion$3.92 billionViewN/AView Earnings Details
1/29/2015Q414$1.94$1.99$4.39 billion$4.49 billionViewN/AView Earnings Details
10/22/2014Q314$1.69$1.71$4.21 billion$4.17 billionViewListenView Earnings Details
7/23/2014Q214$1.62$1.72$4.25 billion$4.32 billionViewN/AView Earnings Details
4/23/2014Q114$1.40$1.53$3.74 billion$3.90 billionViewN/AView Earnings Details
1/31/2014Q413$1.38$1.43$3.31 billion$3.47 billionViewN/AView Earnings Details
10/23/2013Q313$1.28$1.30$3.18 billion$3.19 billionViewListenView Earnings Details
7/24/2013Q2 2013$1.30$1.32$3.22 billion$3.24 billionViewListenView Earnings Details
4/24/2013Q1 2013$1.29$1.37$3.17 billion$3.19 billionViewListenView Earnings Details
1/31/2013Q4 2012$1.28$1.36$3.13 billion$3.26 billionViewListenView Earnings Details
10/24/2012$1.16$1.19ViewN/AView Earnings Details
7/25/2012$1.16$1.22ViewN/AView Earnings Details
4/25/2012$1.11$1.17ViewN/AView Earnings Details
2/1/2012$1.16$1.18ViewN/AView Earnings Details
10/26/2011$1.07$1.07ViewN/AView Earnings Details
7/27/2011$0.98$0.99ViewN/AView Earnings Details
4/27/2011$0.88$0.92ViewN/AView Earnings Details
2/2/2011$0.95$1.00ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Thermo Fisher Scientific (NYSE:TMO)
2017 EPS Consensus Estimate: $9.21
2018 EPS Consensus Estimate: $10.26
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$2.02$2.16$2.07
Q2 20173$2.22$2.27$2.25
Q3 20173$2.24$2.27$2.26
Q4 20173$2.58$2.68$2.63
Q1 20182$2.30$2.31$2.31
Q2 20182$2.49$2.55$2.52
Q3 20182$2.55$2.55$2.55
Q4 20182$2.87$2.90$2.89
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Thermo Fisher Scientific (NYSE:TMO)
Next Dividend:10/16/2017
Annual Dividend:$0.60
Dividend Yield:0.34%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:10.45% (Trailing 12 Months of Earnings)
6.50% (Based on This Year's Estimates)
5.84% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Dividend History by Quarter for Thermo Fisher Scientific (NYSE TMO)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/12/2017quarterly$0.150.33%9/14/20179/15/201710/16/2017
5/18/2017quarterly$0.150.35%6/13/20176/15/20177/17/2017
2/28/2017quarterly$0.150.38%3/13/20173/15/20174/17/2017
11/10/2016quarterly$0.150.4%12/13/201612/15/20161/16/2017
7/7/2016quarterly$0.150.39%9/13/20169/15/201610/17/2016
5/18/2016quarterly$0.150.4%6/13/20166/15/20167/15/2016
2/25/2016quarterly$0.150.46%3/11/20163/15/20164/15/2016
11/12/2015quarterly$0.150.45%12/11/201512/15/20151/15/2016
7/10/2015quarterly$0.150.45%9/11/20159/15/201510/15/2015
5/21/2015quarterly$0.150.45%6/11/20156/15/20157/15/2015
2/26/2015quarterly$0.150.46%3/12/20153/16/20154/15/2015
11/7/2014quarterly$0.150.51%12/11/201412/15/20141/15/2015
7/10/2014quarterly$0.150.51%9/11/20149/15/201410/15/2014
5/21/2014quarterly$0.156/12/20146/16/20147/15/2014
2/27/2014quarterly$0.150.48%3/13/20143/17/20144/15/2014
11/8/2013quarterly$0.150.61%12/12/201312/16/20131/15/2014
7/12/2013quarterly$0.150.68%9/12/20139/16/201310/15/2013
5/23/2013quarterly$0.150.69%6/13/20136/17/20137/15/2013
2/27/2013quarterly$0.150.81%3/13/20133/15/20134/15/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Thermo Fisher Scientific (NYSE:TMO)
Insider Ownership Percentage: 0.49%
Institutional Ownership Percentage: 87.05%
Insider Trades by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Insider Trades by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/5/2017Stephen WilliamsonCFOSell2,500$176.26$440,650.00View SEC Filing  
6/1/2017Marc N CasperCEOSell20,000$172.79$3,455,800.00View SEC Filing  
5/24/2017Daniel P ShineInsiderSell4,688$171.88$805,773.44View SEC Filing  
4/27/2017Thomas W LoewaldInsiderSell1,532$168.76$258,540.32View SEC Filing  
3/15/2017Marc N CasperCEOSell20,000$158.60$3,172,000.00View SEC Filing  
3/15/2017Peter M WilverVPSell9,079$160.73$1,459,267.67View SEC Filing  
3/10/2017Peter M WilverVPSell9,987$158.18$1,579,743.66View SEC Filing  
3/8/2017Thomas W LoewaldInsiderSell7,675$157.39$1,207,968.25View SEC Filing  
3/6/2017Seth H HoogasianVPSell3,142$158.71$498,666.82View SEC Filing  
3/6/2017Stephen WilliamsonCFOSell2,500$158.71$396,775.00View SEC Filing  
3/6/2017Thomas W LoewaldSVPSell4,049$158.71$642,616.79View SEC Filing  
9/2/2016Marc N CasperCEOSell28,797$151.01$4,348,634.97View SEC Filing  
9/1/2016Marc N CasperCEOSell30,000$151.17$4,535,100.00View SEC Filing  
8/29/2016Daniel P ShineSVPSell1,699$152.28$258,723.72View SEC Filing  
8/29/2016Seth H HoogasianVPSell2,270$152.28$345,675.60View SEC Filing  
8/29/2016Thomas W LoewaldInsiderSell3,256$152.28$495,823.68View SEC Filing  
8/26/2016Thomas W LoewaldInsiderSell913$151.92$138,702.96View SEC Filing  
8/10/2016Seth H HoogasianVPSell5,023$156.00$783,588.00View SEC Filing  
8/5/2016C Martin HarrisDirectorSell390$157.33$61,358.70View SEC Filing  
7/13/2016Thomas W LoewaldSVPSell8,025$155.00$1,243,875.00View SEC Filing  
7/5/2016Marc N CasperCEOSell20,000$147.69$2,953,800.00View SEC Filing  
7/1/2016Marc N CasperCEOSell30,000$148.85$4,465,500.00View SEC Filing  
6/15/2016Daniel P ShineSVPSell6,900$148.31$1,023,339.00View SEC Filing  
6/10/2016Peter M WilverVPSell68,200$152.38$10,392,316.00View SEC Filing  
6/3/2016Jim P ManziDirectorSell1,137$153.00$173,961.00View SEC Filing  
6/2/2016Thomas W LoewaldSVPSell15,000$152.84$2,292,600.00View SEC Filing  
5/16/2016Peter E HornstraCAOSell7,811$150.00$1,171,650.00View SEC Filing  
4/26/2016Daniel P ShineSVPSell6,013$146.00$877,898.00View SEC Filing  
4/5/2016Seth H HoogasianVPSell10,000$141.86$1,418,600.00View SEC Filing  
4/4/2016Patrick M DurbinSVPSell16,250$142.18$2,310,425.00View SEC Filing  
3/21/2016Stephen WilliamsonCFOSell10,708$139.50$1,493,766.00View SEC Filing  
3/14/2016Marc N CasperCEOSell30,000$139.28$4,178,400.00View SEC Filing  
3/10/2016Alan J MalusEVPSell25,925$139.05$3,604,871.25View SEC Filing  
3/9/2016Alan J MalusEVPSell15,446$138.50$2,139,271.00View SEC Filing  
3/3/2016Scott M SperlingDirectorSell5,350$137.90$737,765.00View SEC Filing  
3/3/2016Thomas W LoewaldSVPSell3,625$137.28$497,640.00View SEC Filing  
3/1/2016Seth H HoogasianVPSell2,951$135.00$398,385.00View SEC Filing  
2/1/2016Alan J. MalusEVPSell103,400$130.24$13,466,816.00View SEC Filing  
1/15/2016Daniel P. ShineSVPSell6,000$131.77$790,620.00View SEC Filing  
12/14/2015Thomas W. LoewaldSVPSell13,013$134.18$1,746,084.34View SEC Filing  
12/11/2015William G ParrettDirectorBuy1,000$134.16$134,160.00View SEC Filing  
12/7/2015Alan J. MalusEVPSell82,300$135.49$11,150,827.00View SEC Filing  
11/4/2015Seth H HoogasianVPSell1,692$135.00$228,420.00View SEC Filing  
11/3/2015C Martin HarrisDirectorSell531$134.35$71,339.85View SEC Filing  
11/2/2015Jim P. ManziDirectorSell3,050$133.49$407,144.50View SEC Filing  
9/17/2015Marc N CasperCEOSell25,000$130.00$3,250,000.00View SEC Filing  
8/28/2015Alan J MalusEVPSell4,557$127.55$581,245.35View SEC Filing  
7/14/2015Andrew J ThomsonSVPSell5,000$135.23$676,150.00View SEC Filing  
7/14/2015Peter E HornstraCAOSell7,381$136.02$1,003,963.62View SEC Filing  
6/3/2015Tyler JacksDirectorSell15,000$129.95$1,949,250.00View SEC Filing  
6/1/2015Alan J MalusEVPSell40,350$129.54$5,226,939.00View SEC Filing  
5/26/2015Thomas J LynchDirectorSell5,000$131.09$655,450.00View SEC Filing  
5/21/2015Peter M WilverCFOSell28,100$133.00$3,737,300.00View SEC Filing  
4/23/2015Thomas J LynchDirectorSell5,000$130.15$650,750.00View SEC Filing  
4/21/2015Seth H HoogasianVPSell13,256$135.00$1,789,560.00View SEC Filing  
4/13/2015Alan J MalusEVPSell11,032$133.67$1,474,647.44View SEC Filing  
4/13/2015Andrew J ThomsonSVPSell12,425$133.50$1,658,737.50View SEC Filing  
4/1/2015Marc N CasperCEOSell20,000$131.89$2,637,800.00View SEC Filing  
3/30/2015Thomas J LynchDirectorSell5,000$134.40$672,000.00View SEC Filing  
3/30/2015Thomas W LoewaldSVPSell5,307$134.40$713,260.80View SEC Filing  
3/9/2015Alan J MalusEVPSell14,479$128.11$1,854,904.69View SEC Filing  
2/23/2015Edward A PesickaSVPSell28,713$130.93$3,759,393.09View SEC Filing  
2/20/2015Peter M WilverCFOSell50,700$130.12$6,597,084.00View SEC Filing  
2/20/2015Thomas W LoewaldSVPSell15,037$127.94$1,923,833.78View SEC Filing  
2/5/2015Alan J MalusEVPSell50,000$126.83$6,341,500.00View SEC Filing  
12/18/2014Alan J MalusEVPSell11,618$125.20$1,454,573.60View SEC Filing  
11/19/2014Peter E HornstraCAOSell8,363$125.00$1,045,375.00View SEC Filing  
8/27/2014Alan J MalusEVPSell13,115$120.61$1,581,800.15View SEC Filing  
8/27/2014Seth H HoogasianVPSell10,577$120.77$1,277,384.29View SEC Filing  
8/27/2014Thomas W LoewaldSVPSell2,349$120.90$283,994.10View SEC Filing  
7/30/2014Seth H HoogasianVPSell5,103$123.82$631,853.46View SEC Filing  
7/25/2014Thomas W LoewaldSVPSell6,000$125.23$751,380.00View SEC Filing  
4/29/2014Jim ManziDirectorSell3,000$114.85$344,550.00View SEC Filing  
4/28/2014Thomas LoewaldSVPSell8,688$114.49$994,689.12View SEC Filing  
3/24/2014Edward PesickaSVPSell80,044$120.75$9,665,313.00View SEC Filing  
2/26/2014Alan MalusEVPSell7,640$124.11$948,200.40View SEC Filing  
2/14/2014Andrew ThomsonSVPSell16,725$123.14$2,059,516.50View SEC Filing  
2/10/2014Peter HornstraCAOSell9,234$117.72$1,087,026.48View SEC Filing  
2/7/2014Marc CasperCEOSell208,765$115.70$24,154,110.50View SEC Filing  
2/7/2014Peter WilverCFOSell91,897$115.21$10,587,453.37View SEC Filing  
2/6/2014Thomas LoewaldSVPSell22,437$114.24$2,563,202.88View SEC Filing  
2/6/2014William ParrettDirectorSell18,000$114.33$2,057,940.00View SEC Filing  
9/16/2013Alan MalusEVPSell4,000$91.87$367,480.00View SEC Filing  
8/15/2013Alan MalusEVPSell4,000$91.11$364,440.00View SEC Filing  
7/24/2013Edward A PesickaSVPSell80,700$91.00$7,343,700.00View SEC Filing  
6/17/2013Marc N CasperCEOSell43,396$85.58$3,713,829.68View SEC Filing  
6/17/2013Seth H HoogasianVPSell35,431$85.59$3,032,539.29View SEC Filing  
6/10/2013Judy C LewentDirectorSell15,000$85.19$1,277,850.00View SEC Filing  
6/7/2013Edward A PesickaSVPSell167,980$85.28$14,325,334.40View SEC Filing  
5/24/2013C Martin HarrisDirectorSell1,260$87.21$109,884.60View SEC Filing  
5/15/2013Alan J MalusEVPSell4,000$84.43$337,720.00View SEC Filing  
5/14/2013Scott M SperlingDirectorSell8,000$84.65$677,200.00View SEC Filing  
5/7/2013Andrew J ThomsonSVPSell12,700$83.65$1,062,355.00View SEC Filing  
5/7/2013Jim P ManziDirectorSell7,500$82.78$620,850.00View SEC Filing  
11/1/2012Marc N CasperCEOSell125,000$62.49$7,811,250.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Thermo Fisher Scientific (NYSE:TMO)
Latest Headlines for Thermo Fisher Scientific (NYSE:TMO)
Source:
DateHeadline
americanbankingnews.com logoBrokers Offer Predictions for Thermo Fisher Scientific Inc's FY2017 Earnings (TMO)
www.americanbankingnews.com - July 28 at 11:46 AM
nasdaq.com logoEarnings Reaction History: Thermo Fisher Scientific Inc., 44.4% Follow-Through Indicator, 2.7% Sensitive - Nasdaq
www.nasdaq.com - July 28 at 8:53 AM
finance.yahoo.com logoZimmer (ZBH) Tops Q2 Earnings, Drops View on Dull Sales
finance.yahoo.com - July 28 at 8:53 AM
nasdaq.com logoStrategy To YieldBoost Thermo Fisher Scientific From 0.3% To 4.3% Using Options - Nasdaq
www.nasdaq.com - July 27 at 8:27 AM
seekingalpha.com logoThermo Fisher Scientific (TMO) Q2 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - July 27 at 8:26 AM
finance.yahoo.com logoEdited Transcript of TMO earnings conference call or presentation 26-Jul-17 12:30pm GMT
finance.yahoo.com - July 27 at 8:26 AM
americanbankingnews.com logoThermo Fisher Scientific Inc (NYSE:TMO) Posts Earnings Results, Beats Estimates By $0.04 EPS
www.americanbankingnews.com - July 26 at 12:01 PM
seekingalpha.com logoThermo Fisher Scientific beats by $0.03, beats on revenue
seekingalpha.com - July 26 at 9:00 AM
finance.yahoo.com logoShould You Buy Thermo Fisher Scientific Inc. (TMO) Ahead of Earnings?
finance.yahoo.com - July 26 at 9:00 AM
finance.yahoo.com logoThermo Fisher Scientific Reports Second Quarter 2017 Results
finance.yahoo.com - July 26 at 9:00 AM
finance.yahoo.com logoInvestor Network: Thermo Fisher Scientific Inc. to Host Earnings Call
finance.yahoo.com - July 26 at 9:00 AM
finance.yahoo.com logoThermo Fisher beats Street 2Q forecasts
finance.yahoo.com - July 26 at 9:00 AM
finance.yahoo.com logoThermo Fisher (TMO) Beats on Q2 Earnings & Sales Estimates
finance.yahoo.com - July 26 at 9:00 AM
finance.yahoo.com logoWhat Do Analysts Recommend for Thermo Fisher Scientific?
finance.yahoo.com - July 25 at 7:39 AM
finance.yahoo.com logoWhat Analysts Predict for Thermo Fisher’s 2Q17 Revenues
finance.yahoo.com - July 25 at 7:39 AM
americanbankingnews.com logoEquities Analysts Offer Predictions for Thermo Fisher Scientific Inc's Q1 2018 Earnings (TMO)
www.americanbankingnews.com - July 21 at 2:04 PM
americanbankingnews.com logoThermo Fisher Scientific Inc (TMO) Given Buy Rating at Bank of America Corporation
www.americanbankingnews.com - July 21 at 9:30 AM
prnewswire.com logoThermo Fisher Scientific Announces Asia Precision Medicine Research Array for ...
www.prnewswire.com - July 21 at 7:53 AM
americanbankingnews.com logoThermo Fisher Scientific Inc (NYSE:TMO) Upgraded at Cleveland Research
www.americanbankingnews.com - July 20 at 11:13 AM
americanbankingnews.com logoFY2017 EPS Estimates for Thermo Fisher Scientific Inc Raised by Jefferies Group (NYSE:TMO)
www.americanbankingnews.com - July 20 at 9:54 AM
prnewswire.com logoThermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes - PR Newswire (press release)
www.prnewswire.com - July 19 at 8:22 AM
americanbankingnews.com logoThermo Fisher Scientific Inc (TMO) Scheduled to Post Earnings on Wednesday
www.americanbankingnews.com - July 19 at 8:15 AM
finance.yahoo.com logoThermo Fisher Scientific (Finance I) B.V. -- Moody's assigns Baa2 to Thermo Fisher's EUR bonds; outlook stable
finance.yahoo.com - July 18 at 9:06 AM
americanbankingnews.com logoThermo Fisher Scientific Inc (TMO) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - July 18 at 12:48 AM
americanbankingnews.com logoThermo Fisher Scientific's (NYSE:TMO) Overweight Rating Reiterated at Barclays PLC
www.americanbankingnews.com - July 17 at 10:20 PM
americanbankingnews.com logoThermo Fisher Scientific Inc (NYSE:TMO) Expected to Post Quarterly Sales of $4.91 Billion
www.americanbankingnews.com - July 15 at 9:05 AM
streetinsider.com logoThermo Fisher Scientific (TMO) PT Raised to $200 at Wells Fargo on Life Science Tools Industry Update; 'Prioritize ... - StreetInsider.com
www.streetinsider.com - July 14 at 9:14 AM
finance.yahoo.com logoETFs with exposure to Thermo Fisher Scientific, Inc. : July 13, 2017
finance.yahoo.com - July 14 at 9:14 AM
americanbankingnews.com logoWells Fargo & Co Reaffirms "Outperform" Rating for Thermo Fisher Scientific Inc (NYSE:TMO)
www.americanbankingnews.com - July 13 at 9:02 PM
americanbankingnews.com logoZacks: Analysts Expect Thermo Fisher Scientific Inc (NYSE:TMO) to Announce $2.26 EPS
www.americanbankingnews.com - July 13 at 10:49 AM
finance.yahoo.com logoTMO’s Oncomine Target Test Launch Will Boost This Business
finance.yahoo.com - July 13 at 10:30 AM
finance.yahoo.com logoTMO’s Recent Developments in the Small Molecule Research Field
finance.yahoo.com - July 13 at 10:30 AM
americanbankingnews.com logoThermo Fisher Scientific Inc (TMO) Plans $0.15 Quarterly Dividend
www.americanbankingnews.com - July 12 at 5:50 PM
prnewswire.com logoToday's Research Report Coverage on Medical Labs Stocks -- Agilent Technologies, Alere, Quintiles IMS, and Thermo Fisher Scientific
www.prnewswire.com - July 12 at 8:13 AM
americanbankingnews.com logoThermo Fisher Scientific Inc (NYSE:TMO) Upgraded by Zacks Investment Research to Buy
www.americanbankingnews.com - July 11 at 10:14 PM
nasdaq.com logoThermo Fisher at a 52-Week High: What's Driving the Stock?
www.nasdaq.com - July 11 at 8:33 AM
americanbankingnews.com logoThermo Fisher Scientific Inc (TMO) Receives "Buy" Rating from Citigroup Inc.
www.americanbankingnews.com - July 10 at 4:52 PM
finance.yahoo.com logoThermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 26, 2017
finance.yahoo.com - July 4 at 8:03 AM
finance.yahoo.com logoETFs with exposure to Thermo Fisher Scientific, Inc. : June 30, 2017
finance.yahoo.com - July 1 at 8:18 AM
prnewswire.com logoThermo Fisher Scientific Adds Three New Products to Leading Semiconductor ...
www.prnewswire.com - June 30 at 7:19 AM
prnewswire.com logoThermo Fisher Scientific Announces Availability of Two New Immunoassays ...
www.prnewswire.com - June 29 at 7:27 AM
reuters.com logoBRIEF-Thermo Fisher Scientific announces availability of two new immunoassays
www.reuters.com - June 29 at 7:27 AM
americanbankingnews.com logoThermo Fisher Scientific Inc (TMO) Downgraded to Buy at BidaskClub
www.americanbankingnews.com - June 27 at 4:04 PM
americanbankingnews.com logoThermo Fisher Scientific Inc to Post FY2018 Earnings of $10.21 Per Share, Cantor Fitzgerald Forecasts (TMO)
www.americanbankingnews.com - June 26 at 7:51 AM
reuters.com logoBRIEF-FDA approves Thermo fisher Scientific's companion diagnostic test to screen multiple non-small cell lung cancer therapies
www.reuters.com - June 23 at 5:20 AM
americanbankingnews.com logo$4.91 Billion in Sales Expected for Thermo Fisher Scientific Inc (TMO) This Quarter
www.americanbankingnews.com - June 21 at 11:02 AM
finance.yahoo.com logoETFs with exposure to Thermo Fisher Scientific, Inc. : June 20, 2017
finance.yahoo.com - June 21 at 6:11 AM
americanbankingnews.com logoThermo Fisher Scientific Inc (TMO) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - June 21 at 12:38 AM
finance.yahoo.com logoThermo Fisher Scientific, Inc. :TMO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 19, 2017
finance.yahoo.com - June 20 at 8:38 AM
americanbankingnews.com logoThermo Fisher Scientific Inc (TMO) Expected to Post Earnings of $2.26 Per Share
www.americanbankingnews.com - June 19 at 10:28 AM

Social

Chart

Thermo Fisher Scientific (TMO) Chart for Friday, July, 28, 2017

This page was last updated on 7/28/2017 by MarketBeat.com Staff